Stem cell therapy and regenerative medicine have generated extraordinary public interest — and, unfortunately, an equally extraordinary volume of misleading marketing claims. Las Vegas has seen significant growth in clinics offering stem cell injections, platelet-rich plasma (PRP) therapy, exosome treatments, and other regenerative procedures for conditions ranging from orthopedic injuries to anti-aging and sexual wellness. The gap between what the peer-reviewed evidence supports and what some clinics claim is wide, and navigating it requires a clear understanding of FDA oversight, the current state of the science, and the specific risks involved. This guide covers the major regenerative medicine modalities available in Las Vegas: platelet-rich plasma (PRP), bone marrow-derived stem cells, adipose (fat-derived) stem cells, umbilical cord-derived products, and exosomes. For each, we present what the peer-reviewed research actually demonstrates, the FDA's regulatory position, what real patients report, the known risks, and the areas where the evidence is genuinely promising. VegasMedicalTourism.com is a business directory. Nothing in this article constitutes medical advice. Given the significant variation in product quality, regulatory compliance, and evidence base in this field, we particularly strongly encourage you to verify FDA registration status, consult with multiple providers, and seek a second opinion from a physician not affiliated with a stem cell clinic before proceeding with any regenerative medicine treatment.
Understanding FDA Oversight: What Is and Is Not Approved
This is the most important section of this guide. The FDA's regulatory framework for stem cell products is complex, and many patients are unaware that the vast majority of stem cell treatments offered at commercial clinics in the United States are not FDA-approved.
According to the FDA, human cells, tissues, and cellular and tissue-based products (HCT/Ps) are regulated under 21 CFR Part 1271. Products that are "minimally manipulated" and used for "homologous use" (the same function in the donor and recipient) may qualify for regulatory exemption — meaning they do not require FDA approval before use. However, products that are "more than minimally manipulated" or used for "non-homologous use" are regulated as drugs or biological products and require FDA approval through a Biologics License Application (BLA) or Investigational New Drug (IND) application.
What this means in practice: A clinic that takes a patient's own blood, processes it to concentrate platelets (PRP), and injects it into the same patient's knee joint may qualify for the regulatory exemption. A clinic that takes umbilical cord tissue, processes it extensively, and injects it into a patient's bloodstream to treat a systemic condition almost certainly does not qualify — and is operating outside FDA regulations.
The FDA has taken enforcement action against multiple stem cell clinics for marketing unapproved products. According to a 2019 FDA statement, the agency has issued warning letters, injunctions, and seizure orders against clinics offering unapproved stem cell products, including cases where patients suffered serious adverse events including blindness, infections, and tumor formation.
How to verify: Ask any provider: "Is this product FDA-approved, or does it qualify for the 21 CFR 1271.15 exemption? Can you provide the FDA registration number for this facility?" FDA-registered establishments can be verified at fda.gov/vaccines-blood-biologics/tissue-tissue-products/registered-establishments.
Platelet-Rich Plasma (PRP): The Best-Studied Regenerative Treatment
What It Is: PRP involves drawing a small amount of the patient's own blood, centrifuging it to concentrate the platelets (which contain growth factors), and injecting the concentrated plasma into a target area. Because PRP uses the patient's own blood and is minimally manipulated, it generally qualifies for the FDA's regulatory exemption.
What the Research Says: PRP has the most robust evidence base of any regenerative medicine treatment currently offered at commercial clinics:
- Orthopedic applications: A 2021 systematic review and meta-analysis published in the American Journal of Sports Medicine analyzing 18 randomized controlled trials found that PRP injections for knee osteoarthritis produced statistically significant improvements in pain and function compared to placebo or hyaluronic acid at 6–12 months. The effect size was moderate.
- Hair restoration: A 2019 systematic review in the Journal of the American Academy of Dermatology found that PRP injections for androgenetic alopecia (pattern hair loss) produced statistically significant improvements in hair density and thickness in multiple randomized controlled trials.
- Aesthetic applications (PRP facials, microneedling + PRP): Evidence is more limited. A 2019 review in the Journal of Dermatological Treatment found that PRP combined with microneedling produced improvements in acne scarring and skin texture, but noted that study quality was generally low and more large-scale RCTs are needed.
Pros: - Uses patient's own blood — no risk of disease transmission or immune rejection - Generally qualifies for FDA regulatory exemption (minimally manipulated, autologous) - Moderate evidence for knee osteoarthritis and hair restoration - Minimal downtime
Cons: - Evidence is still emerging for many applications - Results vary significantly between patients - Multiple sessions typically required - Not a cure — addresses symptoms rather than underlying disease progression - Cost: $500–$2,500 per session depending on application
What People Say: Patients with knee osteoarthritis who report positive PRP experiences typically describe meaningful pain reduction and improved mobility lasting 6–12 months. Hair restoration patients report gradual improvement in hair density over 3–6 months. Patients who report dissatisfaction most commonly cite insufficient results relative to cost and the need for repeated treatments. One patient shared: *"I had PRP injections in my knee to avoid surgery. I had about 60% pain reduction for about eight months. I've had three rounds now and it's kept me off the operating table."*
Bone Marrow, Adipose & Umbilical Cord Products: What the Evidence Shows
Bone Marrow-Derived Stem Cells (BMSCs): Bone marrow transplantation is the most well-established and FDA-approved form of stem cell therapy, used for decades to treat blood cancers (leukemia, lymphoma) and certain blood disorders. According to the National Marrow Donor Program (NMDP), over 1 million bone marrow transplants have been performed worldwide with well-documented outcomes. However, the use of bone marrow aspirate concentrate (BMAC) for orthopedic or aesthetic applications is a different matter — while some clinical studies show promise for knee osteoarthritis and tendon injuries, the evidence base is still developing and these applications are generally not FDA-approved.
Adipose (Fat-Derived) Stem Cells: Adipose tissue contains mesenchymal stem cells (MSCs) that can be harvested through a mini-liposuction procedure and processed for injection. According to the FDA, most adipose-derived stem cell treatments currently offered at commercial clinics involve "more than minimal manipulation" and therefore require FDA approval — which most do not have. The FDA has specifically warned against the use of stromal vascular fraction (SVF) products derived from adipose tissue for systemic conditions. Clinical research on adipose-derived MSCs is ongoing, with promising early results for osteoarthritis and wound healing, but most applications remain investigational.
Umbilical Cord-Derived Products (Wharton's Jelly, Cord Blood): Umbilical cord tissue products are among the most aggressively marketed stem cell treatments at commercial clinics. According to the FDA, the vast majority of umbilical cord-derived products offered at commercial clinics are not FDA-approved and do not qualify for the regulatory exemption. The FDA has issued multiple warning letters to clinics marketing these products. A 2021 FDA safety communication specifically warned that umbilical cord-derived products marketed for conditions such as autism, Parkinson's disease, ALS, and anti-aging have no proven efficacy and have been associated with serious adverse events.
Exosomes: Exosomes are small vesicles secreted by cells that carry proteins, lipids, and genetic material. They are being studied as potential therapeutic agents and drug delivery vehicles. According to the FDA, exosome products are currently regulated as biological drugs and require FDA approval — no exosome product is currently FDA-approved for clinical use outside of clinical trials. The FDA has issued warning letters to multiple companies marketing exosome products for hair loss, anti-aging, and other conditions.
Risks, Red Flags & How to Protect Yourself
Documented Serious Adverse Events: According to the FDA's MedWatch database and published case reports, serious adverse events associated with unapproved stem cell treatments include: - Blindness following intravitreal injection of adipose-derived stem cells (published in NEJM, 2017) - Spinal cord compression following stem cell injections for ALS - Tumor formation (teratomas) following embryonic stem cell treatments - Systemic infections from contaminated products - Death in rare cases
Red Flags — Avoid Any Provider Who: - Claims stem cell therapy can cure or treat a wide range of unrelated conditions - Cannot provide FDA registration or IND/BLA documentation for the specific product - Charges extremely high fees ($10,000–$50,000+) for treatments with no FDA approval - Discourages you from seeking a second opinion - Cannot provide peer-reviewed published evidence for the specific treatment and indication - Is not a licensed physician (MD or DO)
What to Ask Any Regenerative Medicine Provider: 1. Is this product FDA-approved, or does it qualify for the 21 CFR 1271.15 exemption? 2. Can you provide your FDA facility registration number? 3. What peer-reviewed evidence supports this treatment for my specific condition? 4. What are the known risks and adverse events for this treatment? 5. Are you a licensed physician (MD or DO) in Nevada? 6. What is your protocol if I experience a complication?
Good News: The field of regenerative medicine is advancing rapidly through legitimate clinical research. According to the NIH ClinicalTrials.gov database, there are currently over 6,000 registered clinical trials studying stem cell therapies for a wide range of conditions — many showing genuine promise. The key distinction is between FDA-regulated clinical research (where patient safety is protected) and unregulated commercial treatments (where it may not be). Patients who wish to access cutting-edge regenerative medicine should consider enrolling in an FDA-registered clinical trial rather than paying for unproven commercial treatments.
VegasMedicalTourism.com lists regenerative medicine and stem cell providers across Las Vegas. We particularly encourage you to verify FDA registration, consult multiple providers, and seek independent medical advice before proceeding with any regenerative medicine treatment.
Research Sources & Citations
The following peer-reviewed studies and professional organization guidelines were referenced in this article. Links open external sources in a new tab.
- 1.Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
U.S. Food & Drug Administration (FDA) · 2024
- 2.FDA Statement on Stem Cell Clinic Enforcement Actions
U.S. Food & Drug Administration (FDA) · 2019
- 3.Platelet-Rich Plasma for Knee Osteoarthritis: Systematic Review and Meta-Analysis of RCTs
American Journal of Sports Medicine · 2021
- 4.Platelet-Rich Plasma for Androgenetic Alopecia: Systematic Review
Journal of the American Academy of Dermatology · 2019
- 5.Stem-Cell Therapy for Macular Degeneration — Adverse Events After Intravitreal Injection
New England Journal of Medicine · 2017
- 6.FDA Warns About Stem Cell Therapies — Umbilical Cord-Derived Products
FDA Safety Communication · 2021
- 7.Bone Marrow Transplant: What You Need to Know
National Marrow Donor Program (NMDP / Be The Match) · 2024
- 8.Registered Stem Cell Clinical Trials Database
NIH ClinicalTrials.gov · 2024
- 9.PRP Combined with Microneedling for Acne Scarring: Systematic Review
Journal of Dermatological Treatment · 2019
Frequently Asked Questions
Important Disclaimer
This article is published by VegasMedicalTourism.com for educational and informational purposes only. It does not constitute medical advice, a diagnosis, or a treatment recommendation. The information presented here is drawn from publicly available research and reputable medical organizations; it is not a substitute for professional medical consultation. Every individual's health situation is unique. Before considering any medical or cosmetic procedure, consult with a licensed, board-certified healthcare provider who can evaluate your specific circumstances. VegasMedicalTourism.com is a business directory — we do not endorse, recommend, or verify any specific provider. Always conduct your own due diligence, verify credentials independently through the Nevada State Medical Board and the American Board of Medical Specialties (ABMS), and review multiple providers before making any decision.